Article
Ethical considerations in presymptomatic testing for variant CJD.
Journal of medical ethics - 1 Nov 2005
Duncan R E, Delatycki M B, Collins S J, Boyd A, Masters C L, Savulescu J
Abstract excerpt
Variant Creutzfeldt-Jakob disease (vCJD) is a fatal, transmissible, neurodegenerative disorder for which there is currently no effective treatment. vCJD arose from the zoonotic spread of bovine spongiform encephalopathy. There is now compelling evidence for human to human transmission through blood transfusions from presymptomatic carriers and experts are warning that the real epidemic may be yet to come....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
